Plasma human leukocyte antigen-G (HLA-G) in patients with thyroid cancer

AKIN M., Aral L. A., Yavuz A., Karabacak H., DİKMEN K., BOSTANCI H.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.4, pp.1263-1266, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1611-25
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1263-1266
  • Gazi University Affiliated: Yes

Abstract

Background/aim: A number of tumor markers detected in the serum or pathological specimens using immunohistochemical methods are used for early detection of malignancies and postoperative follow-up. Human leukocyte antigen-G (HLA-G) is a nonclassic HLA class I molecule. Recent studies suggested a relationship between HLA-G positivity and the stage or the phenotype of the malignancy. In this study, the relationship between serum HLA-G positivity and thyroid cancer was investigated.